Your browser doesn't support javascript.
loading
Surufatinib in Chinese Patients with Locally Advanced or Metastatic Differentiated Thyroid Cancer and Medullary Thyroid Cancer: A Multicenter, Open-Label, Phase II Trial.
Chen, Jiaying; Ji, Qinghai; Bai, Chunmei; Zheng, Xiangqian; Zhang, Yuan; Shi, Feng; Li, Xiaojiang; Tang, Pingzhang; Xu, Zhengang; Huang, Rui; Huang, Tao; Pan, Yueyin; Fan, Songhua; Zhou, Jinghong; Su, Weiguo.
Afiliação
  • Chen J; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Ji Q; Department of Head and Neck Surgery, Fudan University Shanghai Cancer Center, Shanghai, China.
  • Bai C; Department of Medical Oncology, Chinese Academy of Medical Science, Peking Union Medical College Hospital, Beijing, China.
  • Zheng X; Department of Head and Neck Tumor, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Zhang Y; Department of Head and Neck Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China.
  • Shi F; Department of Thyroid Medicine, Hunan Cancer Hospital, Changsha, China.
  • Li X; Department of Head and Neck Surgery, Yunnan Cancer Hospital, Kunming, China.
  • Tang P; Department of Head and Neck Surgical Oncology, Cancer Institute (Hospital), Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
  • Xu Z; Department of Head and Neck Surgical Oncology, Cancer Institute (Hospital), Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
  • Huang R; Department of Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Huang T; Department of Thyroid and Breast Surgery, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
  • Pan Y; Tumor Chemotherapy Division, Anhui Province Hospital, Anhui, China.
  • Fan S; Hutchison MediPharma Ltd., Shanghai, China.
  • Zhou J; Hutchison MediPharma Ltd., Shanghai, China.
  • Su W; Hutchison MediPharma Ltd., Shanghai, China.
Thyroid ; 30(9): 1245-1253, 2020 09.
Article em En | MEDLINE | ID: mdl-32075524
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Indóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Sulfonamidas / Neoplasias da Glândula Tireoide / Carcinoma Neuroendócrino / Indóis Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged País/Região como assunto: Asia Idioma: En Revista: Thyroid Assunto da revista: ENDOCRINOLOGIA Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos